Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

cisatracurium besylate How Supplied/Storage and Handling


Cisatracurium Besylate Injection, USP is a clear solution supplied as follows:

Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:

Unit of SaleConcentration

NDC 0409-1098-02

10 mg/5 mL

Carton containing 10 Single-dose Vials

(2 mg/mL)

NDC 0409-1208-01

20 mg/10 mL

Carton containing 10 Multiple-dose Vials

(2 mg/mL)

NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].

Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:

Unit of SaleConcentration

NDC 0409-1103-01

200 mg/20 mL

Carton containing 10 Single-dose Vials

(10 mg/mL)

Intended only for use in the ICU.

Discard unused portion of the 5 mL and 20 mL single-dose vials.


Cisatracurium Besylate Injection, USP should be refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event